ReviewPharmaceutics2020

Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements.

Dima Hattab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.